29544-91-0

Upstream product

• 7439-89-6 iron 
• 2552-45-6 methyl 4-chloro-3,5-dinitrobenzoate 

Downstream Products

• 53882-27-2 4-Chloro-3,5-bis-(ethoxyoxalyl-amino)-benzoic acid methyl ester 
• 61544-93-2 methyl 4-chloro-3,5-bis(N-methylacetamido)benzoate 
• 61544-46-5 methyl 4-chloro-3,5-bis(dimethylamino)benzoate 

Relevant academic research and scientific papers

HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE

The present invention relates to novel hydroxyethylamine compounds of formula (I): (I) having Asp2 (-secretase, BACE1 or Memapsin) inhibitory activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases characterised by elevated-amyloid levels or-amyloid deposits, particularly Alzheimer's disease.

Cyano phenylene dioxamic molecules

Compounds represented below SPC1 And pharmaceutical compositions thereof, the compositions including the non-substituted phenylene dioxamates are useful in the prophylactic treatment of sensitized mammals for allergy and all anaphylactic reactions of a reagin or non-reagin mediated nature.